Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Acta Neurologica Belgica|March 28, 2012
Evaluation of serum oxidant/antioxidant balance in multiple sclerosisAbdullah Acar, M Ugur Cevik, Osman Evliyaoglu, et al.Cureus|November 11, 2024
Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic CancerAsim Armagan Aydin, Erkan Kayikcioglu, Ahmet Unlu, et al.Expert Opinion on Drug Safety|July 1, 2025
Efficacy and safety of omitting 5-fluorouracil bolus in combination chemotherapy regimens for gastrointestinal cancers: a systematic review and meta-analysisYusuf Ilhan, Onur Yazdan Balcık, Elif Sahın, et al.Oncology Research and Treatment|January 16, 2022
Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter StudyMuhammed Mustafa Atci, Baran Akagunduz, Metin Demir, et al.Journal of Chemotherapy (Florence, Italy)|February 17, 2022
The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre studyMuhammed Mustafa Atci, Baran Akagunduz, Metin Demir, et al.World Journal of Gastrointestinal Oncology|June 9, 2025
Novel tumor marker index combining carcinoembryonic antigen and carbohydrate antigen 19-9: New prognostic factor for metastatic colorectal cancerYusuf Ilhan, Onur Yazdan Balcik, Halil Goksel Guzel, et al.Tumori|August 9, 2021
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world studyIbrahim Cil, Ahmet Kucukarda, Muhammed Mustafa Atcı, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 28, 2022
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancerYusuf Ilhan, Ali Murat Tatli, Fatih Teker, et al.Neoplasma|January 9, 2023
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective studyElvina Almuradova, Tugba Basoglu, Erdinc Nayir, et al.Pageof 3